We use our own and third-party cookies to optimize your experience on this site, including to maintain user sessions. Without these cookies our site will not function well. If you continue browsing our site we take that to mean that you understand and accept how we use the cookies. If you wish to decline our cookies we will redirect you to Google.
Already have an account? Sign in.

 Remember Me | Forgot Your Password?

Johnson & Johnson Battles Allegations It Failed To Act On Reported Talcum-Cancer Links

May 11, 2016: 12:00 AM EST
Johnson & Johnson is fighting legal claims and public perception that the company put more emphasis on revenue than on ethics following a court case awarding damages to a woman diagnosed with cancer after years of using its talcum powder. J&J asserts that there is no sufficient medical evidence linking ovarian cancer risk to talcum powder use. Despite scientific facts being cited by the company, however, its brand is likely to suffer significant damage. While it seems that the company ignored information or warnings from some scientific studies highlighting possible links between its product and ovarian cancer, there are no definitive argument for this, according to Wharton lecturer in health care management Robert Field.
"Talcum Trouble: Where Does J&J’s Responsibility Lie?", Knowledge@Wharton , May 11, 2016, © Wharton School of the University of Pennsylvania
Market Segments
Baby Care
Skin Care
North America
United States of America
Comment & Opinion
Companies, Organizations
Legal, Legislation, Regulation, Policy
Products & Brands
Developed by Yuri Ingultsov Software Lab.